Publication:
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

No Thumbnail Available
Date
2019-08-01T00:00:00Z
Authors
Authors
Paitazoglou, Christina
ÖZDEMİR, Ramazan
Pfister, Roman
Bergmann, Martin W.
Bartunek, Jozef
KILIÇ, TEOMAN
Lauten, Alexander
Schmeisser, Alexander
ZOGHİ, MEHDİ
Anker, Stefan
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.
Description
Keywords
Citation
Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W. , Bartunek J., KILIÇ T., Lauten A., Schmeisser A., ZOGHİ M., Anker S., et al., -The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction-, EUROINTERVENTION, cilt.15, ss.403-410, 2019
URI
http://hdl.handle.net/20.500.12645/24191
Collections
Yayınlar - Eserler
Page Views

2

File Downloads

0

Sustainable Development Goals